MedPath

BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study

Not Applicable
Conditions
First Degree Atrioventricular Block
Interventions
Device: Dual chamber pacemaker
Device: Cardiac resynchronization therapy pacemaker
Registration Number
NCT02150538
Lead Sponsor
Gianluca Botto
Brief Summary

This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction , by comparing the treatment with dual-chamber device . The REAL -CRT study is designed to test the hypothesis that, in patients with atrioventricular block of I degree and standard pacing indications , biventricular pacing is superior to single stimulation of the right ventricle (RV) with optimized algorithms for minimization of pacing , as assessed by echocardiography an endpoint defined in terms of maintenance over time of left ventricular ejection fraction (LVEF ) and left ventricular end-systolic volume ( LVESV ) .

Detailed Description

Clinical data suggest that biventricular pacing is able to preserve the myocardial performance more effectively than the right ventricular pacing in patients with atrioventricular block and mild systolic dysfunction . In particular, some studies have shown that medical therapy in these patients could be responsible for an increase in the cumulative percentage of chronic pacing over the 40% threshold , the threshold associated with a higher incidence of atrial fibrillation and hospitalization for heart failure and ventricular arrhythmias . In addition , patients with pre-existing left ventricular dysfunction and indication for pacing standards have improved left ventricular systolic function , exercise capacity and quality of life as a result of biventricular pacing as compared with Right ventricular pacing . These results suggest that biventricular pacing is a feasible option for permanent pacing in patients who have normal systolic function of the left ventricle and that this can be altered from the adverse effects of conventional Right ventricular pacing on systolic function of the left ventricle . This reality has prompted physicians to assess the value and role of cardiac resynchronization therapy (CRT ) in patients with prolonged Atrio-Ventricular (AV) conduction . Note the deleterious effects of chronic stimulation of the right ventricle , the optimal pacing mode should always be considered in these patients at the time of implantation . This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction, by comparing it with the treatment with dual chamber device

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
164
Inclusion Criteria
  • Patients with standard indications to stimulation with a high probability of paced beats according to the clinical evaluation of the investigators:
  • First degree AV block (PR ≥ 220 ms) and indication for pacing
  • Paroxysmal AV block second degree (Type I and Type II) associated with long-PR (PR ≥ 220 ms)
  • Patient must be able to attend all required follow-up visits at the study center.
  • LVEF> 35%

Exclusion Criteria :

  • Patient is less than 18 years of age.
  • Patients with a life expectancy less than 12 months
  • Indication for CRT in class I and II
  • Third-degree AV block
  • Patients currently enrolled in other studies / logs
  • Patients who are not able to understand and sign an informed consent
  • State of current or planned pregnancy within 12 months of enrollment
  • Inability to understand and complete the questionnaire QOL
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Right ventricular stimulationDual chamber pacemakerpatients with conventional Right Ventricular Stimulation (only RV) with optimized algorithms for minimization of pacing
Biventricular StimulationCardiac resynchronization therapy pacemakerPatients with biventricular stimulation (Right Ventricle and Left Ventricle)
Primary Outcome Measures
NameTimeMethod
LVEF2 years

LVEF (Left Ventricular Ejection Fraction: such as the assessment of systolic function of the left ventricle)

LVESV2 years

LVESV (Left Ventricular End Systolic Volume: such as the assessment of left ventricular remodeling)

Secondary Outcome Measures
NameTimeMethod
echocardiographic left ventricular measures2 years

. Structure and cardiac function:

* Left ventricular End Systolic Diameter, Left ventricular End Diastolic Diameter

* Left Ventricular End Systolic

Echocardiographic altrial measures2 years

Size of the left atrium (diameter and volume)

Clinical outcome2 years

Clinical benefit:

* 6 minute walking test

* quality of life questionnaire

* New York Heart Association class

* number and duration of hospitalizations

Atrial fibrillation (AF)2 years

Incidence of AF:

* incidence of persistent AF

* burden of FA

* new onset of AF

Trial Locations

Locations (1)

Azienda Ospedaliera Sant'Anna

🇮🇹

Como, Italy

Azienda Ospedaliera Sant'Anna
🇮🇹Como, Italy
© Copyright 2025. All Rights Reserved by MedPath